3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-N,N-dimethyl-4-oxo-3H-imidazo[4,5-c]pyridine-5(4H)-carboxamide

ID: ALA2281579

PubChem CID: 76327082

Max Phase: Preclinical

Molecular Formula: C27H28N8O2

Molecular Weight: 496.58

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc2ccn(C(=O)N(C)C)c(=O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

Standard InChI:  InChI=1S/C27H28N8O2/c1-4-5-10-23-28-22-15-16-34(27(37)33(2)3)26(36)24(22)35(23)17-18-11-13-19(14-12-18)20-8-6-7-9-21(20)25-29-31-32-30-25/h6-9,11-16H,4-5,10,17H2,1-3H3,(H,29,30,31,32)

Standard InChI Key:  WZAMLFVPDWZIST-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   33.8554   -2.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5650   -2.0613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5622   -1.2387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8536   -0.8334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1473   -2.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1486   -1.2453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3724   -0.9918    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8914   -1.6517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3704   -2.3129    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.8552   -3.2880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.1167   -3.0897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6626   -3.6978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4075   -4.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9526   -5.0789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7531   -4.9104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0056   -4.1288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4588   -3.5243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2972   -5.5129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0430   -6.2907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5889   -6.8977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3892   -6.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6407   -5.9462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0931   -5.3425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2426   -6.4609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6347   -5.9163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9261   -6.3256    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.0963   -7.1260    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9101   -7.2113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.2734   -2.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9805   -2.0591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.0742   -1.6505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6666   -0.9422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8494   -0.9410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4419   -0.2327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2747   -3.2860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.6888   -2.4666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9792   -1.2419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  1 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 15 18  1  0
 19 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  1  0
  2 29  1  0
 29 30  1  0
  8 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 29 35  2  0
 30 36  1  0
 30 37  1  0
M  END

Associated Targets(non-human)

Agtr1b Angiotensin II receptor (AT-1) type-1 (1480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 496.58Molecular Weight (Monoisotopic): 496.2335AlogP: 3.97#Rotatable Bonds: 7
Polar Surface Area: 114.59Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.23CX Basic pKa: 1.75CX LogP: 4.05CX LogD: 2.45
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.36Np Likeness Score: -1.35

References

1. Sharma MC, Kohli DV.  (2013)  A comprehensive structureactivity analysis 2,3,5-trisubstituted 4,5-dihydro-4-oxo-3H-imidazo [4,5-c] pyridine derivatives as angiotensin II receptor antagonists: using 2D- and 3D-QSAR approach,  22  (2): [10.1007/s00044-012-0040-z]

Source